ReviewInternational journal of molecular sciences2026

Revisiting Biomarker-Guided Therapy in EGFR-Mutant Non-Small Cell Lung Cancer with High PD-L1 Expression.

Nuri Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.